MO - Altria Group, Inc.

NYSE - NYSE Delayed Price. Currency in USD
62.55
+0.29 (+0.47%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close62.26
Open62.45
Bid0.00 x 800
Ask0.00 x 45100
Day's Range62.15 - 62.65
52 Week Range53.91 - 74.38
Volume9,754,657
Avg. Volume6,753,690
Market Cap117.917B
Beta0.44
PE Ratio (TTM)11.24
EPS (TTM)5.57
Earnings DateOct 25, 2018
Forward Dividend & Yield3.20 (5.16%)
Ex-Dividend Date2018-09-13
1y Target Est66.59
Trade prices are not sourced from all markets
  • How Oppenheimer's Rosin Is Trading Altria Group
    Bloomberg Video5 days ago

    How Oppenheimer's Rosin Is Trading Altria Group

    Sep.18 -- Alon Rosin, Oppenheimer head of institutional equity derivatives, discusses his options strategy with Bloomberg's Julie Hyman on "Bloomberg Markets: The Close."

  • Will These 3 High-Yield Stocks Generate Value in Dying Industries?
    Motley Fool11 hours ago

    Will These 3 High-Yield Stocks Generate Value in Dying Industries?

    Coal and cigarettes have been declining industries for years, but Alliance Resources Partners, British American Tobacco, and Altria have been able to pay generous dividends to investors. Can that last for much longer?

  • Don’t Get Too Excited About Coca-Cola’s “Cannabis Drink” Buzz
    Motley Fool2 days ago

    Don’t Get Too Excited About Coca-Cola’s “Cannabis Drink” Buzz

    Coca-Cola’s flirtation with the cannabis market won’t boost the beverage maker’s sales anytime soon.

  • Investopedia2 days ago

    7 Defensive Stocks That Are Crushing The Market

    There's been a dramatic shift in investor behavior recently, vaulting defensive sectors such as telecom and consumer staples into market leaders, while relegating tech stocks to laggard status, The Wall Street Journal reports. This is happening even as several major stock indexes have risen to new record highs. "There's been a natural inclination towards more defensive sectors," says Michael Arone, managing director and chief investment strategist at State Street Global Advisors. As investors react to new market highs by anticipating a potential selloff, they have propelled the shares of "safety stocks" such as The Coca-Cola Co. ( KO), Walgreens Boots Alliance Inc. ( WBA).

  • Barrons.com3 days ago

    Big Tobacco Still Has Pricing Power

    Altria, like other tobacco stocks, has had a tough 2018, but it can still raise prices—a critical factor as sales volumes decline, argues Wells Fargo.

  • Is Altria Group a Buy?
    Motley Fool5 days ago

    Is Altria Group a Buy?

    The tobacco giant is facing a lot of obstacles in its path to growth.

  • Why Analysts Are Recommending a ‘Buy’ for Altria Group
    Market Realist5 days ago

    Why Analysts Are Recommending a ‘Buy’ for Altria Group

    Can We Expect an Upside Potential in Altria Stock? Of the 16 analysts covering Altria Group (MO), 62.5% are recommending a “buy” as of September 17, while the remaining 37.5% are recommending a “hold.” None of the analysts are recommending a “sell.” That same day, analysts set an average price target of $66.59, which represents a return potential of 6.7% from the stock price of $62.44. Since the announcement of Altria’s second-quarter earnings on July 26, Stifel and Jefferies have both lowered their target prices.

  • Analysts Expect Altria’s EPS to Rise in the Next Four Quarters
    Market Realist5 days ago

    Analysts Expect Altria’s EPS to Rise in the Next Four Quarters

    Can We Expect an Upside Potential in Altria Stock? For the next four quarters, analysts are expecting Altria Group (MO) to post EPS of $4.17, which represents a 10.6% growth from $3.77 in the corresponding four quarters of the previous year. EPS growth could likely be driven by revenue growth, expansion of net margins, and share repurchases.

  • What Analysts Are Expecting for Altria’s Revenue
    Market Realist6 days ago

    What Analysts Are Expecting for Altria’s Revenue

    Can We Expect an Upside Potential in Altria Stock? For the next four quarters, analysts are expecting Altria Group (MO) to post revenues of $19.8 billion, which represents a 2.1% growth from $19.39 billion in the corresponding four quarters of the previous year. Altria is focusing on innovative product development and packaging, enhanced trade programs, and various marketing and promotional initiatives to drive sales.

  • Can We Expect an Upside Potential in Altria Stock?
    Market Realist6 days ago

    Can We Expect an Upside Potential in Altria Stock?

    As of September 17, Altria Group (MO) stock was trading at $62.44, which represents a 7.9% rise since the announcement of its second-quarter earnings on July 26. On September 12, Scott Gottlieb, commissioner of the FDA, announced that the accelerating trajectory of flavored e-cigarette usage among youths has reached epidemic proportions. The e-cigarette market is dominated by JUUL, which had 72% of the market share as of mid-August, according to Wells Fargo analyst Bonnie Herzog.

  • What FDA's Stance on E-Cigarettes Means for Tobacco Stocks
    Zacks6 days ago

    What FDA's Stance on E-Cigarettes Means for Tobacco Stocks

    The FDA announces directives to curb e-cigarette usage among youngsters. Though this caused tobacco stocks to gain recently, it is yet to be seen if the upside can be sustained.

  • Will Altria Sell Marijuana and Forget About E-Cigarettes?
    Motley Fool8 days ago

    Will Altria Sell Marijuana and Forget About E-Cigarettes?

    Will the biggest domestic tobacco maker start a new cannabis business?

  • No, the FDA's Warning Was Not Good for E-Cigs
    Motley Fool8 days ago

    No, the FDA's Warning Was Not Good for E-Cigs

    Among competing manufacturers, everyone loses if the FDA cracks down on the tobacco companies.

  • Business Wire10 days ago

    FDA Accepts and Files U.S. Smokeless Tobacco Company’s Modified Risk Tobacco Product Application

    U.S. Smokeless Tobacco Company, the U.S. smokeless tobacco industry leader, announced today that the U.S. Food and Drug Administration accepted and filed for substantive scientific review a Modified Risk Tobacco Product application for its moist smokeless tobacco product Copenhagen® Snuff Fine Cut.

  • CNBC10 days ago

    HHS supports FDA's proposed e-cigarette crackdown, HHS Chief Azar says

    Health and Human Services Secretary Alex Azar said the agency supports the Food and Drug Administration's proposed e-cigarette crackdown. The FDA earlier this week threatened to pull e-cigarettes from shelves if manufacturers do not control teen use. The FDA is specifically ordering five brands — Juul, British American Tobacco's Vuse, Altria's MarkTen, Imperial Brands' Blu E-cigs and Japan Tobacco's Logic — to submit plans within 60 days detailing how they will prevent teens from using their products.

  • Should You Be Worried When Altria Group Inc’s (NYSE:MO) Insiders Sell?
    Simply Wall St.10 days ago

    Should You Be Worried When Altria Group Inc’s (NYSE:MO) Insiders Sell?

    Altria Group, Inc., through its subsidiaries, manufactures and sells cigarettes, smokeless products, and wine in the United States. Altria Group’s insiders have divested from 3.17k shares in the large-cap stockRead More...

  • Investopedia10 days ago

    Tobacco Stocks to Gain on FDA E-Cig Crackdown

    The burgeoning popularity of e-cigarettes among young smokers has caused traditional cigarette industry players a great deal of trouble by eating into their market share. As regulators threatened to pull e-cigarettes from shelves if they do not address "widespread" teen use, shares of Altria Group Inc. ( MO), Philip Morris International Inc. ( PM), British American Tobacco Inc. ( BTI) and London-listed Imperial Brands, all closed up over 3%.

  • Altria (MO) in Focus: Stock Moves 6.7% Higher
    Zacks11 days ago

    Altria (MO) in Focus: Stock Moves 6.7% Higher

    Altria (MO) was a big mover last session, as the company saw its rise nearly 7% on the day amid huge volumes.

  • Altria (MO) Shares Up Close to 7% on FDA's Latest Notice
    Zacks11 days ago

    Altria (MO) Shares Up Close to 7% on FDA's Latest Notice

    The FDA reveals serious enforcement actions related to the marketing and sale of e-cigarettes to minors, which may benefit tobacco players like Altria (MO).

  • Why Did Tobacco Stocks Rally on September 12?
    Market Realist11 days ago

    Why Did Tobacco Stocks Rally on September 12?

    On September 12, Scott Gottlieb, the FDA commissioner, announced that the accelerating trajectory of flavored e-cigarette usage among youths has reached an epidemic proportion. The FDA is considering a policy change that would expel e-cigarette products from the market.

  • 3 Big Stock Charts for Thursday: Twitter, Danaher and Northern Trust
    InvestorPlace11 days ago

    3 Big Stock Charts for Thursday: Twitter, Danaher and Northern Trust

    Another wave of bullishness from Advanced Micro Devices (NASDAQ:AMD) likely got the S&P 500 over the hump, with a helping hand from Altria Group (NYSE:MO). The memory maker was down following a downgrade from Goldman Sachs, and the parent company of Snapchat stumbled after BTIG Research suggested the stock could lose another 50% of its value over the course of the next twelve months. The top trading prospects for today are Twitter (NYSE:TWTR), Danaher (NYSE:DHR) and Northern Trust (NASDAQ:NTRS).

  • ACCESSWIRE11 days ago

    Today's Research Reports on Trending Tickers: Altria Group and Philip Morris International

    NEW YORK, NY / ACCESSWIRE / September 13, 2018 / U.S. markets were mixed on Wednesday as technology shares declined, dragging the Nasdaq into the red. The Dow Jones Industrial Average climbed 0.11 percent to close at 25,998.92, while the S&P 500 Index jumped 0.04 percent to close at 2,888.92. The Nasdaq Composite Index dropped 0.23 percent to close at 7,954.23.

  • Why Altria Group, Galapagos, and Laredo Petroleum Jumped Today
    Motley Fool11 days ago

    Why Altria Group, Galapagos, and Laredo Petroleum Jumped Today

    Find out how an FDA ban could help one of these companies.

  • Associated Press11 days ago

    Micron slumps while Altria and Chevron climb

    Cigarette makers rose sharply after the Food and Drug Administration said it is looking at steps to combat "an epidemic" of e-cigarette use by teenagers. The company and its partner Galapagos said a rheumatoid arthritis drug met its goals in a late-stage study. Energy companies and oil prices continued to rise Wednesday with the price of crude.